Core Viewpoint - The current price stability of Bitcoin amidst geopolitical uncertainties may present a potential buying opportunity for investors looking to capitalize on a dip in the cryptocurrency market [1][3]. Market Performance - Bitcoin's price has remained relatively stable, fluctuating between the mid-$60,000 and low-$70,000 range, even after the onset of the Iran war in February 2026 [2][3]. Investment Strategy - Investors considering buying into Bitcoin during this dip may benefit from utilizing a strategy that offers downside protection, such as the Calamos Laddered 90 Series Structured Alt Protection ETF (CBXL) [4][6]. - CBXL invests in four different Calamos Protected Bitcoin ETFs, providing distinct exposure to Bitcoin's price performance while limiting potential losses to a maximum of 10% over a one-year period, excluding fees and expenses [5][6]. Defensive Positioning - Engaging with CBXL allows investors to participate in potential Bitcoin price rallies while maintaining a level of downside security, making it a suitable option for those looking to navigate market volatility [6][7].

Company Overview - Chemed is a diversified services company operating in healthcare and essential home services markets, with a dual-segment model that provides stable revenue streams through hospice care and property maintenance [6] - As of February 12, 2026, Chemed's market capitalization is $6.76 billion, with a revenue of $2.53 billion and a net income of $278.81 million [4] Recent Developments - On February 12, 2026, Barington Companies Management disclosed a new position in Chemed, acquiring 13,000 shares valued at approximately $5.56 million [1][2] - This new position represents 3.65% of Barington Companies Management's reportable U.S. equity assets [8] Financial Performance - Chemed reported third-quarter revenue of $624.9 million, reflecting a year-over-year increase of 3.1%, while adjusted diluted EPS decreased by 6.6% to $5.27 [10] - VITAS revenue increased by 4.2% to $407.7 million, with admissions up 5.6% and average daily census up 2.5% [11] - Roto-Rooter revenue grew by 1.1% to $217.2 million, although margins experienced compression [11] - Chemed ended the quarter with $129.8 million in cash and no current or long-term debt, maintaining full-year guidance of $22.00 to $22.30 per share [11] Market Position and Strategy - Chemed operates through two main segments: VITAS for hospice and palliative care services, and Roto-Rooter for plumbing and water restoration services, targeting both healthcare and property maintenance sectors [9] - The company leverages its national network, brand strength, and operational expertise to maintain a competitive position in its core markets [6] - The recent investment by Barington Companies Management adds defensive exposure to Chemed's portfolio, which is primarily focused on consumer and technology sectors [12]